Compounds > vidarabine phosphate

vidarabine phosphate and Prolymphocytic Leukemia

vidarabine phosphate has been researched along with Prolymphocytic Leukemia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mehta, AB; Smith, OP1
Cervantes, F; Montserrat, E; Rozman, C; Salgado, C1

Other Studies

2 other study(ies) available for vidarabine phosphate and Prolymphocytic Leukemia

ArticleYear
Fludarabine monophosphate for prolymphocytic leukaemia.
    Lancet (London, England), 1990, Sep-29, Volume: 336, Issue:8718

    Topics: Aged; Antimetabolites, Antineoplastic; Arabinonucleotides; Drug Administration Schedule; Humans; Leukemia, Prolymphocytic; Male; Remission Induction; Vidarabine Phosphate

1990
Fludarabine for prolymphocytic leukaemia and risk of interstitial pneumonitis.
    Lancet (London, England), 1990, Nov-03, Volume: 336, Issue:8723

    Topics: Adult; Antimetabolites, Antineoplastic; B-Lymphocytes; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Prolymphocytic; Male; Pulmonary Fibrosis; Risk Factors; Vidarabine Phosphate

1990